SCHAUMBURG, Ill. — Injection maker APP Pharmaceuticals Inc. said Thursday it named Thomas H. Silberg as president and chief executive, succeeding Patrick Soon-Shoing, who will remain chairman. The company also said Richard J. Tajak will become chief financial officer, succeeding Lisa Gopala.
